Home » Topics » Regulatory » Patents

Patents
RSS

5-HT1-like receptor agonists as migraine treatment from Merck & Co.

July 19, 1996

BTG-2403: representative opioid analgesic

July 19, 1996

Aldose reductase inhibitors described by Grelan

July 12, 1996

Otsuka peptide IL-1 production inhibitors in pipeline

July 12, 1996

5alpha-Reductase inhibitors from Kyowa Hakko

July 12, 1996

Selective alpha1A-adrenoceptor antagonists with multiple indications

July 12, 1996

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

July 12, 1996

Teijin's prostaglandin MCP-1/MCAF inhibitors

July 12, 1996

Smooth muscle cell proliferation inhibitors described by American Home Products

July 12, 1996

Endothelin antagonists part of Fujisawa's pipeline

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...